Australian team develops targeted therapy for rare blood cancer
Sheji Halima Researchers in Australia have developed a new targeted therapeutic approach that could improve treatment for myelofibrosis, a rare and serious form of blood cancer that builds up in the bone marrow. Published in the journal Blood, the research focuses on
